Gurugram, September 24, 2025 : Dr. Morepen Pharmacy is strengthening its purpose of affordable
and accessible medicines by ensuring that the recent GST reductions on
medicines are passed on directly to consumers. With a focus on quality generics
and chronic therapies, the mobile
app and pharmacy network provide patients with reliable access to medicines
at lower costs.
The company expressed gratitude to the Government of
India for the progressive reform that eases the healthcare burden for millions
of households. By responsibly passing on the GST benefit, Dr. Morepen Pharmacy
reinforces its role as a trusted partner in delivering transparent, affordable
healthcare.
“Healthcare affordability is a responsibility
we take very seriously,” said Mr.
Varun Suri, CEO – Consumer Division, Dr. Morepen. “Through Dr.
Morepen Pharmacy, our focus is on chronic medicines and high-quality generics,
made even more affordable with the GST benefit. Coupled with the convenience of
our mobile app and last-mile delivery, we are creating a healthcare ecosystem
where patients can rely on both savings and trust. We sincerely thank the
Government for this initiative that empowers consumers directly.”
Dr. Morepen Pharmacy today offers more than
6,000 products across categories including generics, branded medicines,
chronic therapies, wellness products, and OTC essentials. The platform has
already served over 15,000 customers, with one-third being
repeat buyers, reflecting strong consumer trust. With 30-minute
delivery in selected areas and the convenience of ordering directly through
the app, Dr. Morepen Pharmacy is reshaping how India accesses everyday
healthcare. ‘Dr. Morepen Pharmacy’ mobile app is available on IOs and Android.
Powered by the acquisition of Apna Chemist, the
pharmacy combines the strength of a growing retail presence with a mobile-first
digital platform. With 25 years of legacy under the Dr. Morepen brand,
part of the Morepen Group, the pharmacy is uniquely positioned to deliver
not only affordability but also the assurance of quality and care.
By integrating generics, chronic care medicines,
physical stores, and digital accessibility, Dr. Morepen Pharmacy is redefining
the patient experience in India — one rooted in savings, accountability, and
innovation.
About Dr. Morepen
Dr. Morepen, part of the Morepen Group, has a 25-year legacy of putting “Health
in Your Hands” by making quality healthcare both affordable and accessible.
With iconic brands such as Burnol and Lemolate, and
leadership in diagnostics with over 15 million glucometers installed
and 414 million strips sold, Dr. Morepen has become a trusted name in
Indian households. Today, it is enhancing consumer reach through its Dr.
Morepen Pharmacy network and mobile app, offering thousands of products,
affordable generics, and chronic therapies backed by quality standards and
consumer trust.
For more details, visit https://www.drmorepenpharmacy.com/
Media Contact:
Corporate Communications, Dr. Morepen
2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar – III, Sector 20, Gurugram,
Haryana –122016
Email: corporate@morepen.com
Nitika Saini | Nitika.saini@morepen.com
Forward-Looking Statements
This release contains forward-looking statements based on current assumptions
and projections. Actual results may differ materially due to market,
regulatory, or operational factors.
